Jane Paulsen | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Jane Paulsen | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Jane Paulsen | University of Wisconsin Madison | United States

Dr. Jane S. Paulsen, Ph.D., is a Professor of Neurology and Vice Chair for Research at the University of Wisconsin–Madison, where she also contributes to the Department of Neurosciences Graduate Program. Her expertise lies in cognitive, psychiatric, and imaging correlates of neuropsychiatric disorders, with a strong focus on the early detection of brain diseases and the development of innovative methods for clinical trials. She has significantly advanced the understanding of genetic discrimination and the discovery and validation of biological and clinical markers of brain disease, incorporating neuroimaging and omics-based outcomes into her research. Dr. Paulsen completed her Ph.D. in Counseling Psychology at the University of Iowa, followed by postdoctoral training in Neuropsychology at the University of California, San Diego, where she worked on Alzheimer’s and geriatric psychiatry research. Over her career, she has held key positions including Director of the Huntington’s Disease Clinical Research Program at UCSD and has contributed extensively to advancing neuropsychological research and clinical applications. Her scholarly impact includes 4 published documents, 78 citations from 77 documents, and an h-index of 3, reflecting her influence in the fields of neurology, neuropsychology, and cognitive neuroscience.

Profiles: Scopus | Google Scholar | Reserach Gate | linked In

Featured Publications

Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S., & Petersen, R. C. (2014). Classifying neurocognitive disorders: The DSM-5 approach. Nature Reviews Neurology, 10(11), 634–642.

Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., & Paulsen, J. S. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10(4), 204–216.

Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., & Shoulson, I. (2008). Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry, 79(8), 874–880.

Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., Hayden, M. R., & International Huntington’s Disease Collaborative Group. (2004). A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clinical Genetics, 65(4), 267–277.

Levy, M. L., Cummings, J. L., Fairbanks, L. A., Masterman, D., Miller, B. L., Craig, A. H., & Paulsen, J. S. (1998). Apathy is not depression. The Journal of Neuropsychiatry and Clinical Neurosciences, 10(3), 314–319.

Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., & Paulsen, J. S. (2014). Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Disease & Associated Disorders, 28(3), 206–218.

Palmer, B. W., Heaton, R. K., Paulsen, J. S., Kuck, J., Braff, D., Harris, M. J., & Zisook, S. (1997). Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology, 11(3), 437–446.

Plis, S. M., Hjelm, D. R., Salakhutdinov, R., Allen, E. A., Bockholt, H. J., Long, J. D., & Calhoun, V. D. (2014). Deep learning for neuroimaging: A validation study. Frontiers in Neuroscience, 8, 229.

Mohamed, S., Paulsen, J. S., O’Leary, D., Arndt, S., & Andreasen, N. (1999). Generalized cognitive deficits in schizophrenia: A study of first-episode patients. Archives of General Psychiatry, 56(8), 749–754.

Paulsen, J. S., Ready, R. E., Hamilton, J. M., Mega, M. S., & Cummings, J. L. (2001). Neuropsychiatric aspects of Huntington’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 71(3), 310–314.

Kareem Al-Khalil | Cognitive Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Kareem Al-Khalil | Cognitive Neuroscience | Best Researcher Award

Dr. Kareem Al-Khalil | University of Wisconsin – Madison | United States

Kareem I. Al-Khalil is a Multimodal Imaging Scientist at the Institute on Aging, University of Wisconsin-Madison, with extensive expertise in human development, family sciences, and neuroscience. He earned his Ph.D. in Human Development & Family Sciences, focusing on differences in brain activation and connectivity among college students with varying mathematical abilities, and holds dual M.Sc. degrees in Psychology and Experimental Psychology, as well as a B.Sc. in Biology. His professional trajectory spans postdoctoral research and associate positions at Duke University School of Medicine and the Mind Research Network, where he contributed to understanding neurocognitive processes in psychiatric and behavioral contexts. He has also served as a research analyst, teaching assistant, and graduate instructor, gaining substantial experience in experimental design, psychometrics, and cognitive neuroscience. Al-Khalil’s research contributions include peer-reviewed publications on connectomics, brain network disruption in HIV and substance use, and structural connectivity alterations associated with chronic cannabis use. His work has garnered a total of 201 citations, with an h-index of 8 and an i10-index of 7, reflecting his influence in the fields of cognitive neuroscience and neuroimaging. Through his research, he advances understanding of brain function, network connectivity, and cognitive processes in health and disease, integrating behavioral science with multimodal imaging approaches.

Profiles: Google Scholar | Linked In

Featured Publications

Al-Khalil, K., Vakamudi, K., Witkiewitz, K., & Claus, E. D. (2021). Neural correlates of alcohol use disorder severity among nontreatment‐seeking heavy drinkers: An examination of the incentive salience and negative emotionality domains of the … Alcoholism: Clinical and Experimental Research, 45(6), 1200–1214.

Hou, J., Rajmohan, R., Fang, D., Kashfi, K., Al-Khalil, K., Yang, J., & Westney, W. (2017). Mirror neuron activation of musicians and non-musicians in response to motion captured piano performances. Brain and Cognition, 115, 47–55.

Niehuis, S., Reifman, A., Al-Khalil, K., Oldham, C. R., Fang, D., & O’Boyle, M. (2019). Functional magnetic resonance imaging activation in response to prompts of romantically disillusioning events. Personal Relationships, 26(2), 209–231.

Gonzales, J. U., James, C. R., Yang, H. S., Jensen, D., Atkins, L., & Thompson, B. J. (2016). Different cognitive functions discriminate gait performance in younger and older women: A pilot study. Gait & Posture, 50, 89–95.

Calderon-Delgado, L., Barrera-Valencia, M., Noriega, I., & Al-Khalil, K. (2020). Implicit processing of emotional words by children with post-traumatic stress disorder: An fMRI investigation. International Journal of Clinical and Health Psychology, 20(1), 46–53.

Noriega, I., Trejos-Castillo, E., Chae, Y., & Calderon-Delgado, L. (2021). Emotional memory processing in post‐traumatic stress disorder affected Colombian youth. International Journal of Psychology, 56(3), 387–393.

Kashfi, K., Al-Khalil, K., Hou, J., Fang, D., Anderson, R., Rajmohan, R., & Syapin, P. (2017). Hyper-brain connectivity in binge drinking college students: A diffusion tensor imaging study. Neurocase, 23(3–4), 179–186.

Kashfi, K., Fang, D., Hou, J., Al-Khalil, K., Anderson, R., Syapin, P. J., & O’Boyle, M. W. (2017). Spatial attention in binge-drinking and moderate-drinking college students: An fMRI investigation. Alcoholism Treatment Quarterly, 35(3), 260–278.

Swartz, M., Burton, F., Vakamudi, K., Al-Khalil, K., Witkiewitz, K., & Claus, E. D. (2021). Age dependent neural correlates of inhibition and control mechanisms in moderate to heavy drinkers. NeuroImage: Clinical, 32, 102875.

Li-Ru Zhao | Neurogenetics | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Li-Ru Zhao | Neurogenetics | Best Researcher Award

Dr. LR Zhao is a distinguished neuroscientist and professor at the State University of New York Upstate Medical University, with appointments in the Departments of Neurosurgery and Neuroscience & Physiology. He received his M.D. from Hebei Medical College and completed his Ph.D. at Lund University, focusing on neural stem cells, brain plasticity, and neurobiology. His postdoctoral work at the University of Minnesota explored the role of bone marrow stem cells in brain repair. Dr. Zhao’s research career spans multiple institutions, including Northwestern University and Louisiana State University Health Sciences Center, where he progressed from Research Assistant Professor to Associate Professor. His work primarily investigates mechanisms underlying brain repair and regeneration, with emphasis on traumatic brain injury, enriched environment interventions, and neurodegenerative diseases such as Alzheimer’s and CADASIL. He has successfully secured multiple NIH-funded grants, including R01 and R56 awards, totaling several million dollars, and has mentored numerous medical students through summer and research fellowship programs. Dr. Zhao has published 66 peer-reviewed documents, which have been cited 3,238 times by 2,814 documents, yielding an h-index of 27. His contributions have advanced understanding of hematopoietic growth factors in neurorepair, SCF+G-CSF-mediated recovery in chronic TBI, and the cellular mechanisms regulating neurodegeneration and regeneration, establishing him as a leader in translational neuroscience research.

Profiles: Scopus | Linked In

Featured Publications

  • Author(s). (2024). Research guideline recommendations for research on stem cells, human embryos, and gene editing.

  • Author(s). (2024). Hematopoietic growth factors regulate the entry of monocytes into the adult brain via chemokine receptor CCR5. International Journal of Molecular Sciences.

  • Author(s). (2024). Single-cell RNA sequencing reveals immunomodulatory effects of stem cell factor and granulocyte colony-stimulating factor treatment in the brains of aged APP/PS1 mice. Biomolecules.

  • Author(s). (2023). Stem cell factor and granulocyte colony-stimulating factor promote remyelination in the chronic phase of severe traumatic brain injury. Cells.

  • Author(s). (2021). SCF + G-CSF treatment in the chronic phase of severe TBI enhances axonal sprouting in the spinal cord and synaptic pruning in the hippocampus. Acta Neuropathologica Communications.

Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo S. Osorio is a tenured Associate Professor of Psychiatry and Radiology at NYU Grossman School of Medicine, where he directs the Healthy Brain Aging and Sleep Center and serves as Director of the Biomarker Core within the NYU Alzheimer’s Disease Research Center. A physician-scientist, Dr. Osorio investigates the interplay of sleep, vascular, and inflammatory mechanisms in Alzheimer’s disease, integrating multimodal biomarkers, neuroimaging, and detailed clinical phenotyping. He has led several landmark studies, including trials on sleep apnea, amyloid and tau accumulation, brain energetics, and locus coeruleus dysfunction, exploring how sleep and metabolic factors influence cognitive decline and neurodegeneration. His work has significantly advanced translational biomarker development, assay harmonization, and inclusive recruitment in aging research. Dr. Osorio has published over 130 peer-reviewed articles in top journals such as JAMA Neurology, Annals of Neurology, Sleep, Alzheimer’s & Dementia, Lancet, and Brain, contributing to more than 8,369 citing documents, with a total citation count of 9,893 and an h-index of 44. He serves on multiple editorial boards, including Sleep Medicine Reports, and has provided expert peer review for leading journals worldwide. His collaborative network spans the NYU Alzheimer’s Disease Research Center, Mount Sinai, the ENIGMA-Sleep Consortium, and numerous national and international aging and sleep research initiatives, mentoring the next generation of clinician-scientists while shaping the field of sleep and neurodegeneration.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

  1. Author(s). (Year). Disordered sleep and painful diabetic neuropathy (PDN): A review of the literature on pathophysiology, pharmacologic and nonpharmacologic treatment options, and future directions. Journal Name, Volume(Issue), pages.

  2. Author(s). (2025). EEG slow oscillations and overnight spatial navigational memory performance in CPAP-treated obstructive sleep apnea. Sleep, Volume(Issue), pages.

  3. Author(s). (2025). High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer’s disease dementia. Alzheimer’s & Dementia, Volume(Issue), pages.

  4. Author(s). (2025). Impact of Alzheimer’s disease on sleep in adults with Down syndrome. Alzheimer’s & Dementia, Volume(Issue), pages.

  5. Author(s). (2025). Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau. Journal of Clinical Investigation, Volume(Issue), pages.

  6. Author(s). (2025). The stability of slow-wave sleep and EEG oscillations across two consecutive nights of laboratory polysomnography in cognitively normal older adults. Journal of Sleep Research, Volume(Issue), pages.

  7. Author(s). (2025). Two-year longitudinal outcomes of subjective cognitive decline in Hispanics compared to non-Hispanic Whites. Journal of Geriatric Psychiatry and Neurology, Volume(Issue), pages.

  8. Author(s). (Year). Enhancing sleep, wakefulness, and cognition with transcranial photobiomodulation: A systematic review. Journal Name, Volume(Issue), pages.

  9. Author(s). (2024). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Journal of Alzheimer’s Disease, Volume(Issue), pages.

  10. Author(s). (2024). The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people. Immunity and Ageing, Volume(Issue), pages.

Noreen Kamal | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Noreen Kamal | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Noreen Kamal | Dalhousie University | Canada

Dr. Noreen Kamal, Ph.D., P.Eng., is an Associate Professor of Industrial Engineering at Dalhousie University, Canada, with cross-appointments in the Departments of Community Health and Epidemiology and Medicine (Neurology). Her research lies at the intersection of health systems engineering and clinical neuroscience, focusing on the optimization of stroke care systems, development of data-driven quality improvement frameworks, and evaluation of biomedical devices for stroke rehabilitation. Dr. Kamal has played a pivotal role in advancing integrated approaches to enhance the efficiency, safety, and accessibility of acute stroke services across Canada. Prior to joining Dalhousie University, she held academic and leadership positions at the University of Calgary and the University of British Columbia, contributing extensively to clinical research and health technology innovation. Her work bridges engineering, medicine, and health policy, emphasizing interdisciplinary collaboration and patient-centered outcomes. With 107 scientific publications, 8,033 citations, and an h-index of 22, Dr. Kamal has established herself as a recognized scholar in healthcare systems improvement and translational neuroscience. Her scholarly and professional contributions continue to drive evidence-based innovation in stroke systems of care, supporting better clinical outcomes and sustainable health service delivery.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured Publications

Author(s). (2025). Exploring differences in stroke treatment between urban and rural hospitals: A thematic analysis of practices in Canada. Canadian Journal of Neurological Sciences.

Author(s). (2025). Designing a patient outcome clinical assessment tool for modified Rankin Scale: “You feel the same way too”. Informatics.

Author(s). (2025). Predicting ischemic stroke patients to transfer for endovascular thrombectomy using machine learning: A case study. Healthcare (Switzerland).

Author(s). (2025). Incident prescriptions for common cardiovascular medications: Comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems. BMC Cardiovascular Disorders.

Author(s). (2025). Rising out-of-hospital mortality in Canada during 2020–2022: A striking impact observed among young adults. Canadian Journal of Public Health.

Author(s). (2025). Discrete event simulation model of an acute stroke treatment process at a comprehensive stroke center: Determining the ideal improvement strategies for reducing treatment times. Journal of the Neurological Sciences.

Author(s). (2025). Validation of the Passive Surveillance Stroke Severity Score in three Canadian provinces. Canadian Journal of Neurological Sciences.

Author(s). (2025). A stochastic optimization model for designing disaster relief networks with congestion, disruption and distributional ambiguity. Infor.

Author(s). (2025). Improving access and efficiency of acute ischemic stroke treatment across four Canadian provinces: A stepped-wedge trial. Frontiers in Neurology.

Author(s). (2025). The acute stroke system of treatment across Canada: Findings from a national stroke centre survey. Canadian Journal of Neurological Sciences.

Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | University of Sousse | Tunisia

Dr. Chahra Chbili is an Assistant Professor of Pharmacology at the Higher School of Health Sciences and Techniques of Sousse (ESSTSS) and a member of the Research Laboratory of Metabolic Biophysics and Applied Pharmacology (LR/12ES02) at the Faculty of Medicine Ibn El Jazzar of Sousse, Tunisia. Her academic journey spans extensive training in biological sciences, genetics, and medical biotechnology, with a Ph.D. earned with highest honors for her work on the pharmacokinetic and pharmacogenetic study of carbamazepine therapy in epileptic and bipolar patients. Dr. Chbili’s research focuses on pharmacogenetics, pharmacokinetics, and the molecular mechanisms underlying drug efficacy and toxicity. She has contributed significantly to studies exploring the genetic determinants of drug metabolism, including investigations into glutathione-S-transferases in tuberculosis patients with drug-induced hepatotoxicity. Skilled in advanced laboratory techniques such as PCR, FISH, ELISA, and HPLC-MS, she has developed expertise in integrating molecular biology with clinical pharmacology. Dr. Chbili has authored 17 scientific documents, accumulated 138 citations across 123 indexed works, and maintains an h-index of 7, reflecting her impactful contributions to pharmacological and biomedical research in Tunisia and beyond.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

Chbili, C., Mrad, S., Graiet, H., Selmi, M., Maatoug, J., Maoua, M., Abdellaoui, L., Mrizek, N., Nouira, M., Ben Fredj, M., et al. (2024). Randomized, placebo-controlled pilot study investigating the effects of Laurus nobilis tea on lipid profiles and oxidative stress biomarkers in healthy North African volunteers. The North African Journal of Food and Nutrition Research, 8(17), 86–98.

Chbili, C., Fathallah, N., Laadhari, C., Ouni, B., Saguem, S., Ben Fredj, M., Abdelghani, A., Ben Saad, H., & Ben Salem, C. (2022). Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study. Gene, 808, 146019.

Rebai, A., Chbili, C., Ben Amor, S., Hassine, A., Ben Ammou, S., & Saguem, S. (2021). Effects of glutathione S-transferase M1 and T1 deletions on Parkinson’s disease risk among a North African population. Revue Neurologique, 177(1–2), 93–99.

Chbili, C. (2021, August 22). The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson’s disease: A randomized controlled pilot study. Journal article.

Chbili, C., Maoua, M., Selmi, M., Mrad, S., Khairi, H., Limem, K., Mrizek, N., Saguem, S., & Ben Fredj, M. (2020). Evaluation of daily Laurus nobilis tea consumption on lipid profile biomarkers in healthy volunteers. Journal of the American College of Nutrition, 39(6), 518–526.

Rebai, A., Reçber, T., Nemutlu, E., Chbili, C., Kurbanoglu, S., Kir, S., Ben Amor, S., Özkan, S. A., & Saguem, S. (2020). GC-MS based metabolic profiling of Parkinson’s disease with glutathione S-transferase M1 and T1 polymorphism in Tunisian patients. Combinatorial Chemistry and High Throughput Screening, 23(8), 785–794.

Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Published on by Neuroscientists

Prof. Dr. Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Prof. Dr. Elzbieta Paszynska | Poznan University of Medical Sciences | Poland

Professor Elzbieta Paszynska is a distinguished expert in dentistry, serving as Chair of the Department of Integrated Dentistry and Chair of Community Dentistry at Poznan University of Medical Sciences. Her academic focus includes community dentistry, adult comprehensive dental treatment, dental materials, and clinical research in oral health, particularly in patients with eating disorders. She has led numerous significant research projects, including studies on salivary biomarkers, oral health status in eating disorders, and the caries-preventive effects of hydroxyapatite toothpaste in children and adults, collaborating with multiple international institutions. Her research has contributed to over 70 scientific documents with more than 598 citations and an h-index of 13. She has published high-impact works in journals such as Scientific Reports, Frontiers in Public Health, Frontiers in Psychiatry, Nutrients, and the Journal of Dentistry. Her contributions include interdisciplinary projects integrating dentistry, ethics, and public health, and she has coordinated large-scale EU-funded projects and international collaborations. Her work has been recognized with multiple institutional and national awards for scientific excellence, teaching, and professional contributions to dentistry, as well as honors from professional dental associations. She is an active member of national boards and promotes innovation in dental education and research.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • Obesity and central accumulation of fat in school-age children with attention-deficit/hyperactivity disorder. (2025). Scientific Reports.

  • Miescher’s Cheilitis as a Diagnostic and Therapeutic Challenge—A Case Report. (2025). Medicina, Kaunas, Lithuania.

  • Prevalence of Toothache in Adults: A Meta-Analysis of Worldwide Studies. (2025).

  • Pain experience and behavior management: efficacy of photobiomodulation as an adjunct to local anesthesia in MIH patients—a randomized split-mouth clinical study. (2025). Frontiers in Neurology.

  • Clinical evidence of caries prevention by hydroxyapatite: An updated systematic review and meta-analysis. (2025).

Hiroshi Nagase | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Prof. Hiroshi Nagase | Neuropharmacology | Best Researcher Award

Prof. Hiroshi Nagase | University of Tsukuba | Japan

Prof. Hiroshi Nagase is a distinguished Japanese scientist recognized for his pioneering contributions to medicinal chemistry and drug discovery. He earned his B.S., M.S., and Ph.D. degrees in Chemistry from Nagoya University, Japan, and later served as a Visiting Scientist at the University of Minnesota’s Department of Medicinal Chemistry. Dr. Nagase began his professional career at Toray Industries Inc., where he advanced from Researcher to Director in the Basic Research Laboratories. He later joined Kitasato University’s School of Pharmacy as a Professor and subsequently served as a Principal Investigator and Professor at the International Institute for Integrative Sleep Medicine (IIIS) under the World Premier International Research Center Initiative at the University of Tsukuba, where he now holds the title of Professor Emeritus. His academic and research influence extended through adjunct professorships at the University of Tokyo, the University of Nagasaki, Toyohashi Polytechnic College, and Nagoya University. Dr. Nagase has authored 39 scientific documents, which have collectively garnered 279 citations from 189 sources, reflecting his substantial impact on the field. With an h-index of 10, his research continues to inspire advancements in medicinal chemistry, neuropharmacology, and therapeutic innovation.

Profiles: Scopus | Research Gate

Featured Publication

Nagase, H. (2025). Development of novel bioactive alkaloids based on specific reactions of the 4,5-epoxymorphinan framework. Synlett.

[Authors not listed]. (2025). Delta opioid receptor agonists activate PI3K–mTORC1 signaling in parvalbumin-positive interneurons in mouse infralimbic prefrontal cortex to exert acute antidepressant-like effects. Molecular Psychiatry.

Irene Litvan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | University of California San Diego | United States

Dr. Irene Litvan, MD, is the Tasch Endowed Professor of Neurology and Director of the Parkinson and Other Movement Disorders Center at the University of California, San Diego. She is internationally recognized for her pioneering work in movement disorders, particularly Parkinson’s disease and related neurodegenerative conditions. As a leading clinician-scientist, she has directed major multicenter and international initiatives to develop clinical and neuropathologic diagnostic criteria, identify disease biomarkers, and advance therapeutic interventions. Her extensive research spans epidemiologic, genetic, and clinico-pathologic correlation studies that have significantly deepened the understanding of movement disorders. Dr. Litvan’s scholarly impact is reflected in 6 published documents, 10 citations, and an h-index of 1. Throughout her distinguished career, she has received consistent funding support from national and international agencies, industry collaborations, and philanthropic organizations. Beyond her research, she has served as a dedicated mentor, shaping the next generation of neurologists and neuroscientists. Dr. Litvan also leads the UC San Diego Parkinson and Other Movement Disorders Center, fostering clinical excellence and research innovation aimed at improving diagnosis, management, and quality of life for individuals with Parkinson’s disease and other movement-related neurological disorders.

Featured Publications

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626.

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS–SPSP international workshop. Neurology, 47(1), 1–9.

Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Movement Disorders, 32(6), 853–864.

Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Mrs. Claudia Pauciulo | Borghesiana Veterinary Clinic | Italy

Mrs. Claudia Pauciulo is the Head of the Neurology and Neurosurgery Department at Borghesiana Veterinary Clinic in Rome, Italy, and a certified veterinary neurologist completing her ECVN Residency. She holds a Master’s Degree in Diagnostic Imaging and a GP Certificate in Neurology, combining strong academic training with extensive clinical experience in advanced diagnostics (MRI, CT), neurosurgery, and case management. Her research focuses on feline and canine hyperesthesia syndromes, central nervous system lymphoma, intervertebral disc disease, and peripheral neuropathies. Dr. Pauciulo has published as both first author and coauthor in high-impact, peer-reviewed journals, including the Journal of Veterinary Internal Medicine, Journal of the American Veterinary Medical Association, Veterinary Record Case Reports, Journal of Small Animal Practice, and Veterinary Sciences (MDPI). She maintains an active citation record with growing visibility in Scopus- and SCI-indexed publications. Her current h-index is 2, with a total of 10 citations across multiple publications. Through her collaborative research with leading ECVN diplomates and contributions to international neurology congresses, Dr. Pauciulo continues to advance veterinary neuroscience, integrating clinical excellence with innovative research to improve evidence-based therapeutic strategies for neurological disorders in companion animals.

Profiles: Orcid | Linked In

Featured Publication

Pauciulo, C., & Gallucci, A. (2025, September 25). Long‐term outcome of presumptive idiopathic hyperesthesia syndrome in a dog treated with fluoxetine. Veterinary Record Case Reports.